Back Bay Life Science Advisors Appoints Berthold Hackl as Senior Advisor

Advisory Board Adds Europe-Based Leader in Life Science Development, with Focus on European Life Science Community 

Global life science strategy and investment banking firm, Back Bay Life Science Advisors announced the appointment of Berthold Hackl to Back Bay’s Senior Advisory Board. Mr. Hackl is based in Germany and will collaborate with Back Bay’s portfolio of European biopharma, medtech, and diagnostic clients, and Back Bay’s Boston-based, internationally focused team. This addition will further enhance Back Bay’s already strong European presence.

Berthold Hackl has extensive experience and recognition as an executive, advisor, and board member in the life sciences, including biopharma, diagnostics, medtech, and VC investments. He is the founder and principal of Sorrento Investment GmbH, a life sciences investment and advisory in the Frankfurt metropolitan region, Germany. He works extensively in Germany, France and Switzerland, with meaningful reach as well into other European countries.

Mr. Hackl has been an active and visionary participant in the German life science community for many years. His reputation in Germany, together with his long-standing collaboration with Back Bay, enhances the firm’s presence in Germany and Western Europe.

Mr. Hackl brings to Back Bay’s Senior Advisory Board meaningful experience building biopharma and medtech organizations from the ground up. As CEO of invendo medical, a pioneer in the development of single-use gastrointestinal endoscopy products, he shepherded the company from early development to FDA clearance until the generation of first revenues. Invendo was acquired by AMBU in 2017 in a €225m transaction (CPH:AMBU-B).

As General Manager Europe for Eurofins he grew the company’s platform in biopharma and medtech both by successful M&A and organic growth initiatives. Before, Mr. Hackl was engaged in VC investments and strategic players Synthes (now J&J) and Biacore (now Danaher), among others. He also advised the life science activities of boutique M&A firm Taurus Advisory.

“One of Back Bay’s first assignments as a brand-new company in 2010 was a valuable collaboration with Berthold, and we have continued to work together for many years. His experience in the European life sciences community and strong presence in Germany, Switzerland and beyond, reinforces our commitment to US-Europe strategy partnering and development.

Our network of European developers and investors know and welcome Berthold to our Senior Advisory Board,” said Jonathan P. Gertler, MD, CEO of Back Bay Life Science Advisors.

Back Bay has built a strong track record and high-profile presence across the Atlantic with multiple successful project and transaction experiences and contacts across the Nordics, the UK, France, Belgium, the Netherlands, Germany, Switzerland, and Italy.

The Back Bay Senior Advisory Board supports Back Bay’s highly experienced team leading European life sciences firms with exceptional experience in US-Europe life sciences partnerships and includes experienced clinical, regulatory, and development experts.

About Back Bay Life Science Advisors

Back Bay Life Science Advisors is recognized worldwide as a reliable, expert partner for every stage of life science and medtech development. Back Bay is the only Boston-based, global advisory providing seasoned strategic guidance integrated with investment banking expertise. From startup through M&A and beyond, Back Bay is a partner for every stage and sector. www.bblsa.com